Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Litzow

Showing results (131-140 of 457) with videos related to

Pageof 46
Sort By:
British Journal of Haematology|June 19, 2021
Prognostic effect of gender on outcome of treatment for adults with acute myeloid leukaemiaPeter H Wiernik, Zhuoxin Sun, Larry D Cripe, et al.
Blood Cancer Journal|July 6, 2022
Chronic phase CML with sole P190 (e1a2) BCR::ABL1: long-term outcome among ten consecutive casesMaymona G Abdelmagid, Mark R Litzow, Kristen B McCullough, et al.
The American Journal of Medicine|December 3, 2002
Stem cell transplantation for the management of primary systemic amyloidosisMorie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2019
Utilization and Outcomes of Fertility Preservation Techniques in Women Undergoing Allogeneic Hematopoietic Cell TransplantAlexandra Higgins, Zaraq Khan, Charles C Coddington, et al.
Blood Advances|April 25, 2020
A phase 2 study of ATRA, arsenic trioxide, and gemtuzumab ozogamicin in patients with high-risk APL (SWOG 0535)Jeffrey E Lancet, Anna B Moseley, Steven E Coutre, et al.
Leukemia & Lymphoma|September 17, 2004
Thromboembolism in adults with acute lymphoblastic leukemia during induction with L-asparaginase-containing multi-agent regimens: incidence, risk factors, and possible role of antithrombinMichelle A Elliott, Robert C Wolf, Christopher C Hook, et al.
Blood|March 19, 2011
Autologous transplantation gives encouraging results for young adults with favorable-risk acute myeloid leukemia, but is not improved with gemtuzumab ozogamicinHugo F Fernandez, Zhuoxin Sun, Mark R Litzow, et al.
Haematologica|July 28, 2006
A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemiaMark R Litzow, Sandra Lee, John M Bennett, et al.
American Journal of Clinical Pathology|May 15, 2015
Conventional karyotyping and fluorescence in situ hybridization: an effective utilization strategy in diagnostic adult acute myeloid leukemiaRong He, Anne E Wiktor, Curtis A Hanson, et al.
Blood|July 29, 2004
Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literatureAngela Dispenzieri, Alvaro Moreno-Aspitia, Guillermo A Suarez, et al.
Pageof 46

Showing results (131-140 of 457) with videos related to

Sort By:
Pageof 46
British Journal of Haematology|June 19, 2021
Prognostic effect of gender on outcome of treatment for adults with acute myeloid leukaemiaPeter H Wiernik, Zhuoxin Sun, Larry D Cripe, et al.
Blood Cancer Journal|July 6, 2022
Chronic phase CML with sole P190 (e1a2) BCR::ABL1: long-term outcome among ten consecutive casesMaymona G Abdelmagid, Mark R Litzow, Kristen B McCullough, et al.
The American Journal of Medicine|December 3, 2002
Stem cell transplantation for the management of primary systemic amyloidosisMorie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2019
Utilization and Outcomes of Fertility Preservation Techniques in Women Undergoing Allogeneic Hematopoietic Cell TransplantAlexandra Higgins, Zaraq Khan, Charles C Coddington, et al.
Blood Advances|April 25, 2020
A phase 2 study of ATRA, arsenic trioxide, and gemtuzumab ozogamicin in patients with high-risk APL (SWOG 0535)Jeffrey E Lancet, Anna B Moseley, Steven E Coutre, et al.
Leukemia & Lymphoma|September 17, 2004
Thromboembolism in adults with acute lymphoblastic leukemia during induction with L-asparaginase-containing multi-agent regimens: incidence, risk factors, and possible role of antithrombinMichelle A Elliott, Robert C Wolf, Christopher C Hook, et al.
Blood|March 19, 2011
Autologous transplantation gives encouraging results for young adults with favorable-risk acute myeloid leukemia, but is not improved with gemtuzumab ozogamicinHugo F Fernandez, Zhuoxin Sun, Mark R Litzow, et al.
Haematologica|July 28, 2006
A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemiaMark R Litzow, Sandra Lee, John M Bennett, et al.
American Journal of Clinical Pathology|May 15, 2015
Conventional karyotyping and fluorescence in situ hybridization: an effective utilization strategy in diagnostic adult acute myeloid leukemiaRong He, Anne E Wiktor, Curtis A Hanson, et al.
Blood|July 29, 2004
Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literatureAngela Dispenzieri, Alvaro Moreno-Aspitia, Guillermo A Suarez, et al.
Pageof 46